Celldex Therapeutics (CLDX) Change in Cash (2010 - 2026)
Celldex Therapeutics (CLDX) posted quarterly Change in Cash of $6.9 million for Q1 2026, up 161.12% year-over-year from $2.6 million in Q1 2025, and up 195.7% quarter-over-quarter from -$7.2 million in Q4 2025.
Celldex Therapeutics (CLDX) Change in Cash (2010 - 2026) Analysis & Trends
Celldex Therapeutics' Change in Cash history runs 17 years deep, the most recent figure standing at $6.9 million for Q1 2026.
- In Q1 2026, Change in Cash rose 161.12% year-over-year to $6.9 million; the TTM figure through Mar 2026 stood at $18.6 million (up 118.98% YoY), while the FY2025 annual figure was $515000.0, up 107.97% from the prior year.
- Change in Cash for Q1 2026 stood at $6.9 million, up from -$7.2 million in the prior quarter.
- The five-year high for Change in Cash was $80.3 million in Q1 2024, with the low at -$72.3 million in Q2 2024.
- The 5-year median for Change in Cash is -$6.3 million (2024), against an average of -$200823.5.
- The sharpest annual moves came in 2023 and 2025: Change in Cash plunged 933.3% in 2023, then jumped 304.94% in 2025.
- Celldex Therapeutics' Change in Cash stood at $10.8 million in 2022, then rose by 26.13% to $13.7 million in 2023, then sank by 158.79% to -$8.0 million in 2024, then gained by 10.9% to -$7.2 million in 2025, then surged by 195.7% to $6.9 million in 2026.
- Business Quant data shows CLDX's Change in Cash at $6.9 million in Q1 2026, -$7.2 million in Q4 2025, and $13.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Celldex Therapeutics | 3.29 Bn | 2.58 Bn | -2.57 Mn | 11.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.73 Mn |
| Mar 31, 2026 | 6.86 Mn |
| Dec 31, 2025 | -7.17 Mn |
| Sep 30, 2025 | 12.99 Mn |
| Jun 30, 2025 | 5.91 Mn |
| Mar 31, 2025 | -11.22 Mn |
| Dec 31, 2024 | -8.04 Mn |
| Sep 30, 2024 | -6.34 Mn |
| Jun 30, 2024 | -72.34 Mn |
| Mar 31, 2024 | 80.26 Mn |
| Dec 31, 2023 | 13.68 Mn |
| Sep 30, 2023 | -7.09 Mn |
| Jun 30, 2023 | -25.90 Mn |
| Mar 31, 2023 | 24.69 Mn |
| Dec 31, 2022 | 10.85 Mn |
| Sep 30, 2022 | -9.82 Mn |
| Jun 30, 2022 | 3.11 Mn |
| Mar 31, 2022 | -13.85 Mn |
| Dec 31, 2021 | -33.04 Mn |
| Sep 30, 2021 | 28.74 Mn |